Personal information

No personal information available

Activities

Collapse all

Employment (1)

Zuyderland Medisch Centrum Sittard-Geleen: Sittard-Geleen, Limburg, NL

2013-12-01 to present | Consultant (Gastroenterology)
Employment
Source: Self-asserted source
Ad van Bodegraven

Works (11)

Abdominal pain in patients with inflammatory bowel disease in remission: A prospective study on contributing factors

Alimentary Pharmacology & Therapeutics
2023-11 | Journal article
DOI: 10.1111/apt.17718
Contributors: L. M. Janssen; A. Rezazadeh Ardabili; M. J. L. Romberg‐Camps; B. Winkens; R. J. van den Broek; J. Hulst; H. J. A. Verwijs; D. Keszthelyi; D. M. A. E. Jonkers; A. A. van Bodegraven et al.
Source: check_circle
Crossref

Editorial: IBD cost evolution – transitioning from compensating lost productivity to escalating medication expenses

Alimentary Pharmacology & Therapeutics
2023-10 | Journal article
DOI: 10.1111/apt.17683
Contributors: Ashkan Rezazadeh Ardabili; Adriaan A. Van Bodegraven
Source: check_circle
Crossref

Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency

Metabolites
2023-10-06 | Journal article
DOI: 10.3390/metabo13101054
Contributors: Debbie S. Deben; Luc J. J. Derijks; Bianca J. C. van den Bosch; Rob H. Creemers; Annick van Nunen; Adriaan A. van Bodegraven; Dennis R. Wong
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment—TUMMY Study

Pharmaceutics
2023-03-17 | Journal article
DOI: 10.3390/pharmaceutics15030972
Contributors: Merve Sivridaş; Rob H. Creemers; Dennis R. Wong; Paul J. Boekema; Tessa E. H. Römkens; Lennard P. L. Gilissen; Adriaan A. van Bodegraven; Floris C. Loeff; Theo Rispens; Luc J. J. Derijks
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Effectiveness and safety of tofacitinib for ulcerative colitis: two‐year results of the ICC Registry

Alimentary Pharmacology & Therapeutics
2023-01 | Journal article
DOI: 10.1111/apt.17248
Contributors: Tessa Straatmijer; Fiona D. M. van Schaik; Alexander G. L. Bodelier; Marijn Visschedijk; Annemarie C. de Vries; Cyriel Y. Ponsioen; Marieke Pierik; Ad A. van Bodegraven; Rachel L. West; Nanne K. H. de Boer et al.
Source: check_circle
Crossref

Anemia and Iron Deficiency in Outpatients with Inflammatory Bowel Disease: Ubiquitous Yet Suboptimally Managed

Journal of Clinical Medicine
2022-11 | Journal article | Author
DOI: 10.3390/jcm11226843
Contributors: Roberta Loveikyte; Menno Boer; Catharina N. van der Meulen; Rinze W. F. ter Steege; Greetje Tack; Johan Kuijvenhoven; Bindia Jharap; My K. Vu; Lauran Vogelaar; Rachel L. West et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

Classic drugs in the time of new drugs: real‐world, long‐term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease

Alimentary Pharmacology & Therapeutics
2022-09 | Journal article
DOI: 10.1111/apt.17128
Contributors: Ashkan Rezazadeh Ardabili; Steven Jeuring; Zlatan Mujagic; Liekele Oostenbrug; Mariëlle Romberg‐Camps; Daisy Jonkers; Adriaan van Bodegraven; Marieke Pierik
Source: check_circle
Crossref

Editorial: thiopurines in the multidrug era—time to rescue our memories over half a century of experience. Authors' reply

Alimentary Pharmacology & Therapeutics
2022-09 | Journal article
DOI: 10.1111/apt.17186
Contributors: Ashkan Rezazadeh Ardabili; Steven Jeuring; Zlatan Mujagic; Liekele Oostenbrug; Mariëlle Romberg‐Camps; Daisy Jonkers; Adriaan Van Bodegraven; Marieke Pierik
Source: check_circle
Crossref

Editorial: assessment of inflammatory bowel disease—a picture is worth a thousand words

Alimentary Pharmacology & Therapeutics
2021-08 | Journal article
DOI: 10.1111/apt.16476
Contributors: Carmen S. Horjus‐Talabur Horje; Ad A. van Bodegraven
Source: check_circle
Crossref

Editorial: the most commonly used IBD indices still fail to represent real life and subjective patient experience

Alimentary Pharmacology & Therapeutics
2020-06 | Journal article
DOI: 10.1111/apt.15720
Contributors: Rob H. Creemers; Sjaak Bloem; Adriaan A. van Bodegraven
Source: check_circle
Crossref

Editorial: nocebo effect and switching to biosimilars

Alimentary Pharmacology & Therapeutics
2018-03 | Journal article
DOI: 10.1111/apt.14509
Contributors: A. A. van Bodegraven; N. W. Boone
Source: check_circle
Crossref

Peer review (81 reviews for 11 publications/grants)

Review activity for Alimentary pharmacology & therapeutics. (31)
Review activity for Expert opinion on biological therapy (1)
Review activity for Expert opinion on drug metabolism and toxicology (1)
Review activity for Inflammatory bowel diseases. (6)
Review activity for Inflammatory bowel diseases. (15)
Review activity for International journal of molecular sciences. (1)
Review activity for Journal of clinical medicine. (4)
Review activity for Med. (3)
Review activity for Nutrients. (7)
Review activity for PloS one. (7)
Review activity for The American journal of gastroenterology (5)
How many people are using ORCID?